comparemela.com
Home
Live Updates
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement : comparemela.com
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
/PRNewswire/ -- Clinical stage Australian biotech company HaemaLogiX Ltd is pleased to announce it has entered into a co-development agreement with the world...
Related Keywords
Sydney ,
New South Wales ,
Australia ,
Australian ,
Rosanne Dunn ,
Peter Mac ,
Simon Harrison ,
Haemalogix Ltd ,
Peter Maccallum Cancer Centre ,
Peter Maccallum Cancer Centre Mac ,
Peter Mac Centre Of Excellence ,
Kappa Myeloma Antigen ,
Peter Mac Centre ,
Chief Scientific Officer ,
Scientific Advisory Board ,
Multiple Myeloma ,
comparemela.com © 2020. All Rights Reserved.